Flavone-based dual PARP-Tubulin inhibitor manifesting efficacy against endometrial cancer.
Sharma S, Chandra K, Naik A, Sharma A, Sharma R, Thakur A, Grewal AS, Dhingra AK, Banerjee A, Liou JP, Guru SK, Nepali K.
Sharma S, et al. Among authors: nepali k.
J Enzyme Inhib Med Chem. 2023 Dec;38(1):2276665. doi: 10.1080/14756366.2023.2276665. Epub 2023 Nov 2.
J Enzyme Inhib Med Chem. 2023.
PMID: 37919954
Free PMC article.